1. Pathogenic myelin-specific antibodies in multiple sclerosis target conformational proteolipid protein 1-anchored membrane domains
- Author
-
Owens, Gregory P., Fellin, Timothy J., Matschulat, Adeline, Salas, Vanessa, Schaller, Kristin L., Given, Katherine S., Ritchie, Alanna M., Navarro, Andre, Blauth, Kevin, Hughes, Ethan G., Macklin, Wendy B., and Bennett, Jeffrey L.
- Subjects
Immunological research ,Multiple sclerosis -- Development and progression ,Immune response -- Research ,Myelin proteins -- Health aspects -- Physiological aspects ,Monoclonal antibodies -- Health aspects -- Physiological aspects ,Health care industry - Abstract
B cell clonal expansion and cerebrospinal fluid (CSF) oligoclonal IgG bands are established features of the immune response in multiple sclerosis (MS). Clone-specific recombinant monoclonal IgG1 Abs (rAbs) derived from MS patient CSF plasmablasts bound to conformational proteolipid protein 1 (PLP1) membrane complexes and, when injected into mouse brain with human complement, recapitulated histologic features of MS pathology: oligodendrocyte cell loss, complement deposition, and [CD68.sup.+] phagocyte infiltration. Conformational PLP1 membrane epitopes were complex and governed by the local cholesterol and glycolipid microenvironment. Abs against conformational PLP1 membrane complexes targeted multiple surface epitopes, were enriched within the CSF compartment, and were detected in most MS patients, but not in inflammatory and noninflammatory neurologic controls. CSF PLP1 complex Abs provide a pathogenic autoantibody biomarker specific for MS., Introduction Multiple sclerosis (MS) is a chronic autoimmune inflammatory demyelinating disease of the CNS. Multiple molecular mechanisms have been posited as driving lesion pathology (1-3), but the failure to identify [...]
- Published
- 2023
- Full Text
- View/download PDF